Spinal neurosurgery represents a specialized domain within neurosurgery, dedicated to diagnosing, treating, and managing disorders affecting the spine and its surrounding structures. The spine, a vital support structure comprising vertebrae, discs, nerves, and ligaments, plays a pivotal role in mobility, stability, and safeguarding the spinal cord. Spinal neurosurgeons adeptly handle a spectrum of conditions, including spinal tumors, herniated discs, deformities like scoliosis, trauma, and degenerative diseases such as spinal stenosis. Treatment modalities span from conservative measures like physical therapy and pain management to surgical interventions like spinal fusion, discectomy, laminectomy, and spinal cord stimulation, dictated by factors like the patient's condition and overall health. This field demands a multidisciplinary approach, necessitating collaboration with orthopedic surgeons, neurologists, radiologists, and physical therapists to ensure holistic patient care. Technological advancements, notably minimally invasive techniques and robotics, have revolutionized spinal neurosurgery, ushering in reduced recovery times, lower complication rates, and improved patient outcomes. These advancements underscore the continual evolution of spinal neurosurgery, empowering clinicians to provide cutting-edge care to patients grappling with spinal disorders, enhancing their quality of life and functional outcomes.
Title : Atypical presentation of Juvenile myoclonic epilepsy in a 16-year-old female: A case report
George Diaz, Memorial Healthcare Systems, United States
Title : Triple-network dysfunction, ME/CFS, and the NeuroPhysics Treatment Process “A dynamical systems perspective on psychophysical organization and environmental interaction”
Ken Ware, NeuroPhysics Therapy Institute and Research Centre, Australia
Title : Beyond plaques: 10-nanometer-scale pathoconnectomics of Alzheimer’s disease
Ons M Saad, Panluminate Inc., United States
Title : Results from the global phase 3 trial (IB1001-303) evaluating levacetylleucine in children and adults with ataxia-telangiectasia
Chidinma Ejim, IntraBio, United States
Title : A phase 3, multinational, randomized, placebo-controlled, double-blind, crossover trial (IB1001-304) evaluating levacetylleucine in CACNA1A
Chidinma Ejim, IntraBio, United States
Title : Clinical and molecular phenotype of PTRHD1-associated juvenile parkinsonism
Bhavan A Modi, Barrow Neurological Institute at Phoenix Children's, United States